Word

AOBIOME

Status

Dead

Status Code

606

Status Date

Monday, April 11, 2022

Serial Number

87770621

Mark Type

4000

Filing Date

Thursday, January 25, 2018

Published for Opposition

Tuesday, January 8, 2019

Abandoned Date

Monday, April 11, 2022

Trademark Owner History

AOBiome LLC - Owner At Publication

Classifications

5 Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing

10 Stents; intra-uterine contraceptive devices; catheters; pessaries; coatings sold as an integral component of medical stents and other implantable medical devices

Trademark Events

Apr 11, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Apr 11, 2022

Abandonment - No Use Statement Filed

Aug 19, 2021

Notice Of Approval Of Extension Request E-Mailed

Aug 18, 2021

Extension 5 Granted

Aug 16, 2021

Extension 5 Filed

Aug 18, 2021

Case Assigned To Intent To Use Paralegal

Aug 16, 2021

Teas Extension Received

Feb 11, 2021

Notice Of Approval Of Extension Request E-Mailed

Feb 9, 2021

Extension 4 Granted

Feb 9, 2021

Extension 4 Filed

Feb 9, 2021

Teas Extension Received

Sep 4, 2020

Notice Of Approval Of Extension Request E-Mailed

Sep 2, 2020

Extension 3 Granted

Sep 2, 2020

Extension 3 Filed

Sep 2, 2020

Teas Extension Received

Mar 6, 2020

Notice Of Approval Of Extension Request E-Mailed

Mar 4, 2020

Extension 2 Granted

Mar 4, 2020

Extension 2 Filed

Mar 4, 2020

Teas Extension Received

Jul 24, 2019

Notice Of Approval Of Extension Request E-Mailed

Jul 22, 2019

Extension 1 Granted

Jul 22, 2019

Extension 1 Filed

Jul 22, 2019

Teas Extension Received

Jul 22, 2019

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 22, 2019

Teas Change Of Owner Address Received

Mar 5, 2019

Noa E-Mailed - Sou Required From Applicant

Jan 8, 2019

Official Gazette Publication Confirmation E-Mailed

Jan 8, 2019

Published For Opposition

Dec 19, 2018

Notification Of Notice Of Publication E-Mailed

Nov 20, 2018

Approved For Pub - Principal Register

Nov 20, 2018

Examiner's Amendment Entered

Nov 20, 2018

Notification Of Examiners Amendment E-Mailed

Nov 20, 2018

Examiners Amendment E-Mailed

Nov 20, 2018

Examiners Amendment -Written

Nov 13, 2018

Teas/Email Correspondence Entered

Nov 13, 2018

Correspondence Received In Law Office

Nov 13, 2018

Teas Response To Office Action Received

May 15, 2018

Notification Of Priority Action E-Mailed

May 15, 2018

Priority Action E-Mailed

May 15, 2018

Priority Action Written

May 7, 2018

Assigned To Examiner

Feb 6, 2018

New Application Office Supplied Data Entered In Tram

Jan 29, 2018

New Application Entered In Tram